Besides, researchers have also suggested distinct biomarkers (e.g., fetuin A, chemerin, and cathepsin D) or predictive scores (including the Pediatric NAFLD score) for pediatric NAFLD diagnosis [26]. This evidence concerns the gene RARRES2 and metabolic dysfunction-associated steatotic liver disease.